Igor Mochalkin

2.3k total citations
26 papers, 1.0k citations indexed

About

Igor Mochalkin is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Igor Mochalkin has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Genetics. Recurrent topics in Igor Mochalkin's work include Chronic Lymphocytic Leukemia Research (5 papers), Enzyme Structure and Function (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Igor Mochalkin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Enzyme Structure and Function (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Igor Mochalkin collaborates with scholars based in United States, Switzerland and Italy. Igor Mochalkin's co-authors include Russell F. Doolittle, Zhe Yang, Sandra Lightle, A. Tulinsky, John D. Knafels, C. Kendall Stover, J. Richard Miller, Beisong Cheng, Lakshmi Narasimhan and Bayard R. Huck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Igor Mochalkin

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Mochalkin United States 18 510 228 171 121 119 26 1.0k
Maciej Wieczorek Poland 20 831 1.6× 120 0.5× 143 0.8× 84 0.7× 51 0.4× 83 1.4k
Hao Shao United States 21 909 1.8× 182 0.8× 162 0.9× 41 0.3× 123 1.0× 47 1.3k
Wentao Fu United States 15 474 0.9× 176 0.8× 127 0.7× 109 0.9× 277 2.3× 25 1.4k
Walter H.J. Ward United Kingdom 18 985 1.9× 102 0.4× 264 1.5× 62 0.5× 203 1.7× 33 1.6k
Douglas R. Dougan United States 19 918 1.8× 126 0.6× 378 2.2× 219 1.8× 152 1.3× 32 1.6k
Nathan A. Lack Türkiye 22 668 1.3× 306 1.3× 124 0.7× 59 0.5× 79 0.7× 55 1.4k
Ciarán N. Cronin United States 22 967 1.9× 54 0.2× 115 0.7× 154 1.3× 63 0.5× 38 1.6k
David A. Scott United States 19 979 1.9× 156 0.7× 223 1.3× 78 0.6× 320 2.7× 50 1.5k
Renae M. Crosby United States 17 1.1k 2.1× 248 1.1× 167 1.0× 54 0.4× 57 0.5× 27 1.7k
Jan Eickhoff Germany 20 1.1k 2.2× 147 0.6× 129 0.8× 61 0.5× 33 0.3× 38 1.8k

Countries citing papers authored by Igor Mochalkin

Since Specialization
Citations

This map shows the geographic impact of Igor Mochalkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Mochalkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Mochalkin more than expected).

Fields of papers citing papers by Igor Mochalkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Mochalkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Mochalkin. The network helps show where Igor Mochalkin may publish in the future.

Co-authorship network of co-authors of Igor Mochalkin

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Mochalkin. A scholar is included among the top collaborators of Igor Mochalkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Mochalkin. Igor Mochalkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mochalkin, Igor, et al.. (2020). Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni. International Journal for Parasitology Drugs and Drug Resistance. 13. 73–88. 9 indexed citations
2.
Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit. Bioorganic & Medicinal Chemistry Letters. 28(17). 2939–2944. 19 indexed citations
3.
Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(20). 3307–3311. 4 indexed citations
4.
Caldwell, Richard D., Lesley Liu‐Bujalski, Igor Mochalkin, et al.. (2018). Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk. Bioorganic & Medicinal Chemistry Letters. 28(21). 3419–3424. 15 indexed citations
5.
Huck, Bayard R. & Igor Mochalkin. (2017). Recent progress towards clinically relevant ATP-competitive Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(13). 2838–2848. 29 indexed citations
6.
Chen, Shih-Hsun, Youyan Zhang, Robert D. Van Horn, et al.. (2016). Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120. Cancer Discovery. 6(3). 300–315. 117 indexed citations
7.
Warmus, Joseph S., Cheryl L. Quinn, Clarke Taylor, et al.. (2012). Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC. Bioorganic & Medicinal Chemistry Letters. 22(7). 2536–2543. 28 indexed citations
8.
Casimiro‐Garcia, Agustin, Christopher F. Bigge, Wayne L. Cody, et al.. (2009). Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action. Bioorganic & Medicinal Chemistry. 17(6). 2501–2511. 17 indexed citations
9.
Mochalkin, Igor, John D. Knafels, & Sandra Lightle. (2008). Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB‐78485 inhibitor. Protein Science. 17(3). 450–457. 48 indexed citations
10.
Mochalkin, Igor, Sandra Lightle, Lakshmi Narasimhan, et al.. (2008). Structure of a small‐molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site. Protein Science. 17(3). 577–582. 43 indexed citations
11.
Mochalkin, Igor, J. Richard Miller, A.G. Evdokimov, et al.. (2008). Structural evidence for substrate‐induced synergism and half‐sites reactivity in biotin carboxylase. Protein Science. 17(10). 1706–1718. 67 indexed citations
12.
Mochalkin, Igor, Sandra Lightle, Yaqi Zhu, et al.. (2007). Characterization of substrate binding and catalysis in the potential antibacterial target N‐acetylglucosamine‐1‐phosphate uridyltransferase (GlmU). Protein Science. 16(12). 2657–2666. 37 indexed citations
13.
Holsworth, Daniel D., Mehran Jalaie, Thomas R. Belliotti, et al.. (2007). Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(13). 3575–3580. 19 indexed citations
14.
Powell, Noel A., Fred L. Ciske, Daniel D. Holsworth, et al.. (2007). Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors. Bioorganic & Medicinal Chemistry. 15(17). 5912–5949. 43 indexed citations
15.
Doolittle, Russell F., Zhe Yang, & Igor Mochalkin. (2001). Crystal Structure Studies on Fibrinogen and Fibrin. Annals of the New York Academy of Sciences. 936(1). 31–43. 34 indexed citations
16.
Mochalkin, Igor, et al.. (2000). Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1. Acta Crystallographica Section D Biological Crystallography. 56(3). 294–303. 12 indexed citations
17.
Mochalkin, Igor & A. Tulinsky. (1999). Structures of thrombin retro-inhibited with SEL2711 and SEL2770 as they relate to factor Xa binding. Acta Crystallographica Section D Biological Crystallography. 55(4). 785–793. 7 indexed citations
18.
Mochalkin, Igor, Beisong Cheng, Olga Klezovitch, Angelo M. Scanu, & A. Tulinsky. (1999). Recombinant Kringle IV-10 Modules of Human Apolipoprotein(a):  Structure, Ligand Binding Modes, and Biological Relevance. Biochemistry. 38(7). 1990–1998. 17 indexed citations
19.
Chang, Yuan‐Chih, Igor Mochalkin, Stephen G. McCance, et al.. (1998). Structure and Ligand Binding Determinants of the Recombinant Kringle 5 Domain of Human Plasminogen,. Biochemistry. 37(10). 3258–3271. 77 indexed citations
20.
Castellino, F.J., Stephen G. McCance, Yu‐Chu Chang, Igor Mochalkin, & A. Tulinsky. (1997). 159 Structure and ligand binding properties of the kringle 5 domain of human plasminogen. Fibrinolysis & proteolysis. 11. 45–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maciej Wieczorek Breakdown of academic impact, for papers by Hao Shao Breakdown of academic impact, for papers by Wentao Fu Breakdown of academic impact, for papers by Walter H.J. Ward Breakdown of academic impact, for papers by Douglas R. Dougan Breakdown of academic impact, for papers by Nathan A. Lack Breakdown of academic impact, for papers by Ciarán N. Cronin Breakdown of academic impact, for papers by David A. Scott Breakdown of academic impact, for papers by Renae M. Crosby Breakdown of academic impact, for papers by Jan Eickhoff
Rankless by CCL
2026